ProChon Biotech, Ltd. is a privately owned biotechnology company focused on modulation the fibroblast growth factor (FGF) system to enable it to create more effective solutions for tissue regeneration. ProChon Biotech, Ltd. is pioneering new technologies that are redefining the focus of clinical orthopedics from traditional metal implants, plates and screw to biology-based products for tissue regeneration, expanding treatment options, improving patient's quality of life and reducing healthcare costs.
